Cancilico
0 followers
About Cancilico
Cancilico pioneers AI-powered image-based diagnostics for healthcare, focusing on hematological cancers. Their flagship MyeloAID software automates classification and counting of bone marrow cells to generate rapid myelograms, aiming to improve diagnostic accuracy and reduce lab time. Based in Dresden, Germany, the company develops AI-driven solutions and services that integrate with existing laboratory infrastructure for research and clinical workflows.